Mirataz - the first licensed veterinary medicinal product for body weight gain in cats experiencing poor appetite
MIRATAZ is the first licensed veterinary medicinal product for body weight gain in cats experiencing poor appetite. Veterinarians can confidently recommend this effective topically applied product for cats with unintended weight loss.
The Active ingredient, mirtazapine, addresses reduced appetite and in a clinical study, MIRATAZ resulted in significant weight gain in cats in as little as 14 days following topical application of 2 mg per day.
MIRATAZ gives you a practical way to manage your patient’s weight loss without administration of oral medication and does not rely on the cat to eat to be medicated. Formulated using proprietary Accusorb technology, MIRATAZ achieves measurable plasma concentrations of mirtazapine in cats.
MIRATAZ was safe both locally and systemically in a clinical study.
Contact us for the clinical study - the safety profile of MIRATAZ - 230 cats were enrolled in a field study to assess the clinical safety and effectiveness of MIRATAZ.
If your cat is losing weight, it could be a sign of a more serious underlying disease. It’s important to talk to your veterinarian immediately about changes in your cat’s eating habits or weight.
Mirataz a product from Dechra proudly distributed by TVG